Botulinum toxin A for patients with orofacial dystonia: Prospective, observational, single-centre study
International Journal of Oral and Maxillofacial Surgery Dec 07, 2017
Ruiz-de-Leon-Hernandez G, et al. - The efficacy of intramuscular botulinum toxin type A (BTX-A) as a method of controlling the symptoms of focal facial dystonia was investigated in this study. In the treatment of focal dystonia, BTX-A could be used. It also provided reproducible results.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
